Tuesday, October 20 · 5-minute read
Good morning. If your organization is weighing a value-based contract, this one's for whoever sits in the room before the term sheet exists. These deals rarely fail in the clinic. They fail in the questions nobody asked before signing.
Marcus walked out of the signing meeting feeling good. His health system had just landed a value-based contract with one of its largest commercial payers, built around shared savings on a chronic-disease population. Six months later he was walking his CFO through a variance report that showed a number nobody had modeled: the downside risk his team assumed was capped wasn't, and the payer had structured the agreement so the system absorbed the first tranche of losses before any shared-savings protection kicked in.
Marcus hadn't misread the contract. He'd never seen the version of it that mattered, because the clinical, IT, and compliance teams who understood the operational reality of that population got pulled in after the terms were already set.
That's not a Marcus problem. That's the default sequence at most health systems moving into value-based care right now, and it's why so many of these contracts look good on signing day and expensive twelve months later.
The part that usually gets skipped
Value-based contracting is moving faster than most organizations' internal readiness. Commercial payers, Medicare Advantage plans, and Managed Medicaid plans are all pushing toward these models at once, and the pressure to say yes to a value-based agreement, any value-based agreement, has outpaced the harder work of figuring out whether your organization can actually deliver on what it's agreeing to.
The external problem is real: payers want data infrastructure, risk-sharing terms, and outcome benchmarks that most provider organizations aren't fully built for yet. But the problem that actually costs money is internal. It's negotiating the contract before the people who have to operationalize it are in the room. It's treating value-based readiness as a legal and finance exercise instead of a clinical and operational one.
I've negotiated enough of these to know the pattern. The contract terms are rarely the failure point. The failure point is what wasn't asked before the terms were finalized.
What to settle before you sign
Five (5) things need to be nailed down before a value-based agreement gets your signature, and none of them belong exclusively to legal or finance.
Data and reporting infrastructure. Payers want real transparency now: records requests, documentation timelines, coding accuracy. Your IT, HIM, and billing teams need to be built to deliver it without drowning. Bring them into the negotiation early. Finding out post-signature that your systems can't produce what the contract requires is an expensive way to learn that lesson.
The actual shape of the risk. Understand the downside before you get excited about the upside. If your organization has a low risk tolerance, or is legally restricted from taking on financial risk the way many governmental providers are, full-risk arrangements may not be a fit at all. Upside-only structures can still work, but the payer is pricing in the fact that they're carrying the downside, so your upside gets scaled down to match. Know which trade you're actually making.
Provider alignment. Clinical leaders need to understand the financial mechanics and the incentives before the contract closes, not after. Have that conversation before you're deep into negotiations, ideally before you decide to pursue value-based contracting at all. A physician who doesn't understand what they're being incentivized to do won't deliver the outcome the contract is betting on.
Staffing for the outcomes you're promising. Patient outcome and satisfaction benchmarks require a care management infrastructure that's hired, trained, and running before the contract goes live, not being built while the clock is already ticking. Pharmacy oversight belongs here too. Formulary compliance and fill rates are a growing share of the cost picture in almost every value-based structure.
Legal and compliance at the table, not after the fact. Bring your chief compliance officer and general counsel in during negotiation, not for a final review. Regulatory requirements around value-based arrangements keep shifting, and their expertise catches structural problems that finance and clinical teams aren't positioned to see.
None of these fix Marcus's contract after the fact. All five would have caught the problem before it was signed.
What changes when you get this right
The health systems getting value-based care right aren't the ones with the best legal teams. They're the ones where finance, clinical leadership, compliance, and operations sat in the same room before a term sheet existed, and where the contract reflects what the organization can actually deliver rather than what looked attractive on a slide.
Marcus's system renegotiated the risk structure at the next contract cycle, this time with clinical and IT leadership involved from the first meeting. The revised agreement capped downside exposure at a level the finance team had actually modeled, and the shared-savings performance in year one covered the loss from year one twice over. The difference wasn't a better payer. It was a different sequence.
Before your next value-based negotiation starts, get clinical leadership, IT, compliance, and finance in the same room and walk through these five items together. Do it before the term sheet, not after.
To paraphrase this newsletter's tagline, the value-based contract is not the finish line. It's the starting condition for everything your organization has to deliver for the next several years, and the terms you accept on signing day are the terms you'll be living inside long after that room has emptied out.
Call to Action: If your organization has been through a value-based negotiation that looked good on paper and got harder in year one, tell me what changed in the comments. These stories are what make the next reader's negotiation go better.
Forward this to whoever on your team is heading into a value-based term sheet this quarter, before they head into the room.
See you next Tuesday,
Kevin
P.S. Got a question you'd like me to tackle in a future issue? Just hit reply.
X · LinkedIn · RSS · KevinWatsonBarron.com
About the Author: Kevin W. Barron, MBA, FHFMA, FACHE is a nationally recognized healthcare contracting and payer relations executive with over 30 years of experience in healthcare finance. He is an author, speaker, and mentor to emerging leaders in healthcare finance. Subscribe to his free weekly newsletter at KevinWatsonBarron.com
Disclaimer: This article is provided for general informational and educational purposes only. It reflects my personal views and observations based on professional experience in healthcare finance, managed care, payer relations, and revenue cycle operations. It should not be interpreted as legal, financial, regulatory, actuarial, or reimbursement advice. The content is not intended to represent the official position of my employer, any payer, provider, professional association, or other organization with which I may be affiliated. Readers should consult their own legal, financial, compliance, actuarial, or operational advisors before making decisions based on the issues discussed. Any references to payers, providers, regulations, market trends, or reimbursement practices are intended for discussion and education only and should not be construed as a statement about any specific contract, negotiation, patient matter, or confidential business arrangement.
